Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
Hemasphere|November 15, 2019
Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML PatientsBianca R Schnell, Katja Seipel, Ulrike Bacher, et al.Structure (London, England : 1993)|June 13, 2006
Structure of a central component of the yeast kinetochore: the Spc24p/Spc25p globular domainRonnie R Wei, Jason R Schnell, Nicholas A Larsen, et al.Nuklearmedizin. Nuclear Medicine|September 16, 2005
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives]K Schomäcker, M Dietlein, R Schnell, et al.International Journal of Cancer|May 8, 2000
Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID miceS Barth, M Huhn, B Matthey, et al.Leukemia|January 19, 2000
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxinR Schnell, E Vitetta, J Schindler, et al.Heredity|April 2, 2009
Parentage analysis and outcrossing patterns in cacao (Theobroma cacao L.) farms in CameroonM I B Efombagn, O Sounigo, A B Eskes, et al.Leukemia & Lymphoma|December 30, 1998
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphomaM Reiser, R Schnell, G Straub, et al.Journal of Structural Biology|November 12, 2009
Two-dimensional crystallization conditions of human leukotriene C4 synthase requiring adjustment of a particularly large combination of specific parametersG Zhao, M C Johnson, J R Schnell, et al.Der Pathologe|December 22, 2005
[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma]P Borchmann, K Behringer, A Josting, et al.Leukemia & Lymphoma|August 26, 1998
Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphomaR Schnell, E Vitetta, J Schindler, et al.Pageof 12